BENJAMIN CLUBB: Open Payments
NPI 1982353454 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 54 payments from 12 companies in 2025. Trend: 2023 $785 · 2024 $370 · 2025 $1,345
Food & beverage: $1,311Education: $34
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 23 | $592 |
| CSL Behring | 4 | $111 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| GENZYME CORPORATION | 4 | $95 |
| PFIZER INC. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Genentech USA, Inc. | 2 | $42 |
Products named: NEFFY, DUPIXENT, TRELEGY ELLIPTA, Haegarda, TAKHZYRO, PANZYGA, AIRSUPRA, Xolair.
Industry payments across NC — which companies pay providers there.
